SHAREHOLDER ALERT: WeissLaw LLP Investigates Zix Corporation

NEW YORK, Nov. 8, 2021 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Zix Corporation (“Zix” or the “Company”) (NASDAQ: ZIXI), in connection with the proposed acquisition of the Company by Open Text Corporation (“OpenText”) (NASDAQ: OTEX) via a tender offer.  Under the terms of the merger agreement, the Company’s shareholders will receive $8.50 per share in cash for each share of Zix common stock that they hold.  The transaction is valued at approximately $860 million.

If you own Zix shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:
Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
305 Broadway, 7th Floor
New York, NY  10007
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw LLP is investigating whether (i) Zix’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $8.50 per-share offer price adequately compensates Zix’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. Notably, the offer price is $2.50 below the $11.00 median price target set by analysts following the Company. Indeed, at least one analyst set a price target for the Company of $12 per share, $3.50 above the per-share offer price. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]


Related Links

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload the CAPTCHA.